SCHEMBL30939863

SCHEMBL30939863

CCC(CC)COC(=O)C1(N[P@](=O)(OC[C@H]2CC[C@](C#N)(c3ccc4c(N)ncnn34)O2)Oc2ccccc2)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30939853 0.90 — —
SCHEMBL18636608 0.88 CYP3A4 (0.32) —
SCHEMBL24148708 0.88 CYP3A4 (0.32) —
SCHEMBL30939804 0.87 TMPRSS2 (0.38) —
SCHEMBL31684173 0.87 TMPRSS2 (0.38) —
SCHEMBL31684154 0.87 TMPRSS2 (0.38) —
SCHEMBL31684122 0.83 TMPRSS2 (0.30) —
SCHEMBL31684215 0.83 TMPRSS2 (0.30) —
SCHEMBL31684147 0.83 TMPRSS2 (0.30) —
SCHEMBL25012912 0.82 CSNK1A1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120464-A1 NUCLEOTIDE ANALOG, AND COMPOSITION AND USE THEREOF 深圳市塔吉瑞生物医药有限公司 2024-06-13 — — WO disclosed
Send feedback